Travere Therapeutics Inc at Evercore ISI HealthCONx Conference (Virtual) Transcript
Hi, there. My name is Liisa Bayko. I am one of the analysts at Evercore ISI. And welcome to HealthCONx, our last virtual one. We will be migrating to Miami next year, so I'm super excited for that. And hopefully next year we will be talking to Travere about how great their launch has been next year in Miami.
So I want to turn it over to Eric to give a brief introduction to himself and to Travere.
Excellent. Well, Liisa, thank you so much to you and Evercore for hosting us. And you're absolutely right. We will look next year to be talking about some great performance. We have a really exciting year ahead of us for Travere.
So I'm Eric Dube; I am the President and CEO of Travere. I have been with the company for four years and have been really honored to help in shepherding sparsentan through the clinic. And we've got our first PDUFA date in February of next year.
We're a rare disease company that's exclusively focused on rare disease. And I
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |